HCPCS Code for Neupogen: A Comprehensive Guide

Neupogen (filgrastim) is a vital medication used to stimulate the production of white blood cells, particularly in patients undergoing chemotherapy, bone marrow transplants, or suffering from severe chronic neutropenia. Proper coding and billing for Neupogen are essential for healthcare providers to ensure accurate reimbursement. The Healthcare Common Procedure Coding System (HCPCS) provides specific codes for Neupogen, streamlining the billing process for medical professionals.

This guide explores the HCPCS code for Neupogen, its medical applications, billing procedures, and key considerations for healthcare providers. Whether you’re a medical coder, pharmacist, or healthcare administrator, this article provides in-depth insights into Neupogen’s coding, administration, and financial aspects.

What is Neupogen?

Neupogen (filgrastim) is a granulocyte colony-stimulating factor (G-CSF) biologic drug developed by Amgen. It works by stimulating the bone marrow to produce neutrophils, a type of white blood cell crucial for fighting infections.

Key Features of Neupogen:

• Brand Name: Neupogen

• Generic Name: Filgrastim

• Drug Class: Colony-stimulating factor

• FDA Approval Year: 1991

• Manufacturer: Amgen

Neupogen is available in single-dose vials and prefilled syringes, typically administered via subcutaneous (SC) or intravenous (IV) injection.

Medical Uses of Neupogen

Neupogen is primarily prescribed for:

1. Chemotherapy-Induced Neutropenia

   • Reduces infection risk in cancer patients undergoing myelosuppressive chemotherapy.

2. Bone Marrow/Stem Cell Transplantation

   • Accelerates neutrophil recovery post-transplant.

3. Severe Chronic Neutropenia (SCN)

   • Treats congenital, cyclic, or idiopathic neutropenia.

4. Mobilization of Peripheral Blood Progenitor Cells (PBPCs)

   • Used in stem cell collection before transplantation.

HCPCS Code for Neupogen: Overview

The HCPCS (Healthcare Common Procedure Coding System) is used for billing Medicare, Medicaid, and other insurance providers. Neupogen has a designated HCPCS code for accurate claims processing.

Primary HCPCS Code for Neupogen

Additional Related Codes

Understanding HCPCS Codes

HCPCS codes are divided into two levels:

1. Level I: CPT codes (for physician services)

2. Level II: Codes for medical supplies, drugs, and equipment (e.g., Neupogen)

Neupogen falls under Level II HCPCS codes, specifically in the J-codes category for injectable drugs.

Neupogen HCPCS Code Breakdown

J1440: Filgrastim Injection

• 1 mcg = 1 billing unit

• Typical Dosage: 5 mcg/kg/day

• Billing Example:

  • If a patient receives 300 mcg, the billed units would be 300.

Q5101: Biosimilar Filgrastim

• Covers biosimilars like Zarxio (filgrastim-sndz).

Billing and Reimbursement for Neupogen

Medicare Coverage

• Medicare Part B covers Neupogen for approved indications.

• Average Sales Price (ASP) + 6% reimbursement model applies.

Coding Tips for Accurate Billing

✔ Use J1440 for brand-name Neupogen.
✔ Use Q5101 for biosimilar versions.
✔ Include diagnosis codes (e.g., D70 for neutropenia).

Neupogen Dosage and Administration

Side Effects and Precautions

Common Side Effects

• Bone pain

• Headache

• Fatigue

• Injection site reactions

Serious Risks

• Splenic rupture

• Acute respiratory distress syndrome (ARDS)

• Leukocytosis (high WBC count)

Neupogen vs. Biosimilars

Cost and Insurance Coverage

• Average Cost: $300–$500 per 300 mcg vial

• Insurance Coverage: Medicare Part B, most private insurers

Clinical Studies and Efficacy

• Reduces febrile neutropenia risk by 50% (ASCO guidelines).

• Improves neutrophil recovery post-chemotherapy.

Conclusion

Neupogen (filgrastim) is a critical medication for managing neutropenia, with specific HCPCS codes (J1440, Q5101) for billing. Proper coding ensures accurate reimbursement, while understanding dosage and side effects optimizes patient care. Biosimilars offer cost-effective alternatives, making Neupogen accessible to more patients.

Frequently Asked Questions (FAQs)

1. What is the HCPCS code for Neupogen?

The primary HCPCS code is J1440 for brand-name Neupogen.

2. Does Medicare cover Neupogen?

Yes, Medicare Part B covers Neupogen for approved indications.

3. What are the side effects of Neupogen?

Common side effects include bone pain, headache, and fatigue.

4. Can Neupogen be used for stem cell mobilization?

Yes, at a dosage of 10 mcg/kg/day.

5. What is the difference between Neupogen and Zarxio?

Zarxio is a biosimilar with the same efficacy but at a lower cost.

Additional Resources

• FDA Neupogen Label

• CMS HCPCS Codes

• ASCO Neutropenia Guidelines